Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

Clinical trial NCT01618734 · COMPLETED

Trial details

NCT number: NCT01618734
Sponsor: Henri Mondor University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Thrombocytopenia Thrombopoietin Receptor Agonist

Start date: 2012-01-01
Primary completion: 2012-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.